Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East: A scoping review
- PMID: 35689428
- DOI: 10.1111/liv.15338
Hepatitis delta virus infection prevalence, diagnosis and treatment in the Middle East: A scoping review
Abstract
Hepatitis D virus (HDV) infection is a global public health concern, especially because of its unique existence in the presence of hepatitis B virus infection. HDV infection is estimated to affect 12 million people globally. Having a clearer understanding of its prevalence in all regions of the world is essential for helping direct preventive and early interventional treatment. This mini-review assessed the literature over the last 10 years to determine the prevalence, diagnostic means and treatment guidelines available for HDV in the Middle East. The search found limited data available in 21 articles, of which 18 were studies focused on Iran. Prevalence rates ranged dramatically among the countries, and none of the 12 countries included in the search had specific HDV guidelines. This review highlights the urgent need for more precise data for the Middle East region to help establish early diagnosis and treatment options for HDV.
Keywords: Middle East; guidelines; hepatitis D virus; prevalence; treatment.
© 2022 The Authors. Liver International published by John Wiley & Sons Ltd.
Comment in
-
Response to "Hepatitis delta virus infection in the Middle East".Liver Int. 2023 Jan;43(1):257. doi: 10.1111/liv.15451. Epub 2022 Oct 17. Liver Int. 2023. PMID: 36205593 No abstract available.
-
Hepatitis delta virus infection in the Middle East.Liver Int. 2023 Jan;43(1):256. doi: 10.1111/liv.15450. Epub 2022 Oct 13. Liver Int. 2023. PMID: 36205630 No abstract available.
References
REFERENCES
-
- Lee AU, Lee C. Hepatitis D review: challenges for the resource-poor setting. Viruses. 2021;13(10):1912. doi:10.3390/V13101912
-
- Stockdale AJ, Kreuels B, Henrion MYR, et al. The global prevalence of hepatitis D virus infection: systematic review and meta-analysis. J Hepatol. 2020;73(3):523-532. doi:10.1016/J.JHEP.2020.04.008
-
- Miao Z, Zhang S, Ou X, et al. Estimating the global prevalence, disease progression, and clinical outcome of Hepatitis Delta virus infection. J Infect Dis. 2020;221(10):1677-1687. doi:10.1093/infdis/jiz633
-
- WHO. Hepatitis D. https://www.who.int/news-room/fact-sheets/detail/hepatitis-d. Accessed December 17, 2021.
-
- Yurdaydin C, Toy M. Hepatitis Delta virus infection: a large burden after all? J Infect Dis. 2020;221(10):1573-1575. doi:10.1093/INFDIS/JIZ634

